Legal status · Canada
Is BPTES legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. BPTES is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
BPTES in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the BPTES profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing BPTES is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What BPTES is
The tool compound behind a distinct senolytic idea: senescent cells run on glutamine to neutralise their own acidity, so blocking glutaminase kills them. Demonstrated in mice and cells. BPTES itself has never been given to a person.
The glutaminolysis route to senolysis was set out in Science in 2021. Lysosomal membrane damage lowers the internal pH of senescent cells, which induces kidney-type glutaminase; the resulting glutaminolysis produces ammonia that neutralises the acidity and keeps the cell alive.
Mechanism: Established in human cells and mice: senescent cells have lowered intracellular pH from lysosomal membrane damage, which induces kidney-type glutaminase and the ammonia production that buffers it. BPTES binds GLS1 allosterically and blocks that.
Regulatory history: Not approved and not in clinical development. A preclinical research compound with no registered human trial. The orally bioavailable glutaminase inhibitor in this class, telaglenastat, reached randomised oncology trials and is also unapproved.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for BPTES at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
BPTES in other countries
Frequently asked questions
Is BPTES legal in Canada?
No. BPTES is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy BPTES in Canada?
No approved product exists to buy. In Canada BPTES is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is BPTES Health Canada approved?
No. In Canada BPTES is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved and not in clinical development. A preclinical research compound with no registered human trial. The orally bioavailable glutaminase inhibitor in this class, telaglenastat, reached randomised oncology trials and is also unapproved.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for BPTES live on its compound profile.
BPTES profileThis page is general information about the regulatory status of BPTES in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.